P01009 (A1AT_HUMAN) Homo sapiens (Human)
Alpha-1-antitrypsin UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
40 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM |
Heteromer | 1×NAG; 2×NAG; 1×CYS; | ||||
| Assess | ||||||
| NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN |
Heteromer P00760; | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX |
Heteromer P00760; | |||||
| Assess | ||||||
| Cleaved alpha-1-antitrypsin polymer |
Heteromer | |||||
| Assess | ||||||
| Fab fragment of an antibody selective for wild-type alpha-1-antitrypsin in complex with its antigen |
Heteromer | 2×NA; 1×SO4; | ||||
| Assess | ||||||
| Fab fragment of a native monomer-selective antibody in complex with alpha-1-antitrypsin |
Heteromer | |||||
| Assess | ||||||
| Active site distortion is sufficient for proteinase inhibit second crystal structure of covalent se… |
Heteromer P00772; | |||||
| Assess | ||||||
| Crystal structure of an alpha-1-antitrypsin trimer | homo-3-mer | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF CLEAVED ANTITRYPSIN POLYMER | homo-2-mer | |||||
| Assess | ||||||
| THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM | homo-2-mer | 1×NAG; 2×NAG; 1×CYS; | ||||
| Assess | ||||||
| THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM | homo-2-mer | 1×NAG; 2×NAG; 1×CYS; | ||||
| Assess | ||||||
| Cleaved antitrypsin with P8-P6 Asp | homo-2-mer | |||||
| Assess | ||||||
| Cleaved antitrypsin with P10 Pro, and P9-P6 Asp | homo-2-mer | |||||
| Assess | ||||||
| A 2.1 ANGSTROM STRUCTURE OF AN UNCLEAVED ALPHA-1-ANTITRYPSIN SHOWS VARIABILITY OF THE REACTIVE CENT… | monomer | 5×ZN; 1×BME; | ||||
| Assess | ||||||
| ALPHA1-ANTITRYPSIN | monomer | |||||
| Assess | ||||||
| UNCLEAVED ALPHA-1-ANTITRYPSIN | monomer | |||||
| Assess | ||||||
| Alpha-1-antitrypsin (Ala250Met) in the native conformation | monomer | |||||
| Assess | ||||||
| Crystal structure of native alpha-1-antitrypsin with seven stabilising mutations | monomer | 2×GOL; 2×OXM; | ||||
| Assess | ||||||
| alpha 1-antitrypsin (C232S) complexed with GSK716 | monomer | 1×R7Z; 1×SO4; | ||||
| Assess | ||||||
| ALPHA-1 ANTITRYPSIN C232S COMPLEXED WITH CMPD3 | monomer | 2×GOL; 1×UL2; | ||||
| Assess | ||||||
| Alpha-1-antitrypsin (Ser36Arg/Glu78Arg/Glu266Arg) in the native conformation | monomer | |||||
| Assess | ||||||
| 2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A CANONICAL TEMPLATE FOR ACTIVE SERPINS | monomer | |||||
| Assess | ||||||
| Crystal structure of alpha-1-antitrypsin, crystal form B | monomer | 1×CL; | ||||
| Assess | ||||||
| Intact recombined alpha1-antitrypsin mutant PHE 51 to LEU | monomer | |||||
| Assess | ||||||
| Native alpha-1-antitrypsin at 1.5 Angstrom (Cys232Ser) | monomer | 1×GLY; 1×EDO; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of native alpha-1-antitrypsin with seven stabilising mutations | monomer | 3×GOL; | ||||
| Assess | ||||||
| Alpha-1-antitrypsin Queen's (K154N) variant | monomer | 2×GLY; 1×H3B; | ||||
| Assess | ||||||
| ALPHA-1 ANTITRYPSIN (C232S) COMPLEXED WITH cmpd 11 | monomer | 1×UKZ; 1×GOL; | ||||
| Assess | ||||||
| 1.92 angstrom crystal structure of A1AT:TTAI ternary complex | monomer | 2×GOL; | ||||
| Assess | ||||||
| Interactions causing the kinetic trap in serpin protein folding | monomer | 1×Z6W; | ||||
| Assess | ||||||
| Crystal Structure of Gly117Phe Alpha1-Antitrypsin | monomer | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN | monomer | 1×NAG; | ||||
| Assess | ||||||
| 1.8 Angstrom structure of intact native wild-type alpha-1-antitrypsin | monomer | |||||
| Assess | ||||||
| Alpha-1-antitrypsin Queen's (Lys154Asn) variant | monomer | 1×GLY; | ||||
| Assess | ||||||
| Alpha-1-antitrypsin - Sydney variant (G192C) | monomer | |||||
| Assess | ||||||
| 2.2 Angstrom Crystal Structure of Thr114Phe Alpha1-Antitrypsin | monomer | |||||
| Assess | ||||||
| Alpha-1-antitrypsin - Sydney variant (G192C) | monomer | |||||
| Assess | ||||||
| Crystal structure of alpha-1-antitrypsin complexed with citrate | monomer | 1×CIT; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION | monomer | |||||
| Assess | ||||||
| Crystal structure of alpha-1-antitrypsin, crystal form A | monomer | |||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1qlp.1.A | monomer | 0.83 | 100.00 | |||
| Assess | ||||||
2 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 6i7u.1.A | monomer | 0.84 | 98.80 | ||
| Assess | ||||||
| Isoform 3 | 2qug.1.A | monomer | 0.83 | 100.00 | ||
| Assess | ||||||